An international network cohort study comparing risk of thrombosis with thrombocytopenia associated with Vaxzevria, Comirnaty, Spikevax, or Janssen Covid 19 vaccines
Latest Information Update: 29 Sep 2022
At a glance
- Drugs Ad26.COV2 S (Primary) ; AZD 1222 (Primary) ; Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
Most Recent Events
- 29 Sep 2022 New trial record
- 28 Aug 2022 Results presented at the 38th International Conference on Pharmacoepidemiology and Therapeutic Risk Management